Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Takebe, Naoko
One or more keywords matched the following items that are connected to Takebe, Naoko
Item TypeName
Concept Pyrimidines
Academic Article Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.
Academic Article Activity of the Ubiquitin-activating Enzyme Inhibitor TAK-243 in Adrenocortical Carcinoma Cell Lines, Patient-derived Organoids, and Murine Xenografts.
Academic Article KIT as a therapeutic target in metastatic melanoma.
Academic Article Phase II study of dasatinib in patients with advanced non-small-cell lung cancer.
Academic Article SLFN11 Inactivation Induces Proteotoxic Stress and Sensitizes Cancer Cells to Ubiquitin Activating Enzyme Inhibitor TAK-243.
Academic Article Drug delivery of oral anti-cancer fluoropyrimidine agents.
Academic Article Inhibition of calcineurin combined with dasatinib has direct and indirect anti-leukemia effects against BCR-ABL1(+) leukemia.
Academic Article A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.
Academic Article Phase II Study of Samotolisib in Children and Young Adults With Tumors Harboring Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Pathway Alterations: Pediatric MATCH APEC1621D.
Academic Article A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors.
Academic Article Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E.
Search Criteria
  • Pyrimidines